E 801 E 801
Pill imprint E 801 E 801 has been identified as Rifampin 150 mg.
Rifampin is used in the treatment of leprosy; meningococcal meningitis prophylaxis; nasal carriage of staphylococcus aureus; tuberculosis, prophylaxis; tuberculosis, latent (and more), and belongs to the drug class rifamycin derivatives. Risk cannot be ruled out during pregnancy.
Rifampin 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Rifampin Images
- Imprint:
-
E 801
E 801 - Strength:
- 150 mg
- Color:
- Orange
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
corn starch
D&C Yellow No. 10
docusate sodium
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
magnesium stearate
microcrystalline cellulose
sodium benzoate
sodium lauryl sulfate
ferrosoferric oxide
magnesium silicate
titanium dioxide
D&C Red No. 28
- Drug Class:
- Rifamycin derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00185-0801
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5472 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More Rifampin resources
- Rifampin (Wolters Kluwer)
- Rifampin Capsules (Wolters Kluwer)
- rifampin (Cerner Multum)
- rifampin Intravenous (Micromedex) - Includes Dosage Information
- rifampin Oral, Intravenous (Micromedex) - Includes Dosage Information
- Rifampin (AHFS DI)
- Rifampin Capsules (FDA)
- Rifampin Injection (FDA)
- Rifampin (Wolters Kluwer)


